Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Multi-Attribute Method for Quality Control of Therapeutic Proteins.

Rogstad S, Yan H, Wang X, Powers D, Brorson K, Damdinsuren B, Lee SL.

Anal Chem. 2019 Oct 16. doi: 10.1021/acs.analchem.9b03808. [Epub ahead of print]

PMID:
31618017
2.

B cell receptor induced Fc receptor-like 5 expression is mediated by multiple signaling pathways converging on NF-κB and NFAT.

Damdinsuren B, Dement-Brown J, Li H, Tolnay M.

Mol Immunol. 2016 May;73:112-21. doi: 10.1016/j.molimm.2016.04.001. Epub 2016 Apr 8.

PMID:
27065451
3.

Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors.

Franco A, Damdinsuren B, Ise T, Dement-Brown J, Li H, Nagata S, Tolnay M.

J Immunol. 2013 Jun 1;190(11):5739-46. doi: 10.4049/jimmunol.1202860. Epub 2013 Apr 24.

4.

Fc receptor-like 5 promotes B cell proliferation and drives the development of cells displaying switched isotypes.

Dement-Brown J, Newton CS, Ise T, Damdinsuren B, Nagata S, Tolnay M.

J Leukoc Biol. 2012 Jan;91(1):59-67. doi: 10.1189/jlb.0211096. Epub 2011 Oct 25.

PMID:
22028333
5.

Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells.

Olkhanud PB, Damdinsuren B, Bodogai M, Gress RE, Sen R, Wejksza K, Malchinkhuu E, Wersto RP, Biragyn A.

Cancer Res. 2011 May 15;71(10):3505-15. doi: 10.1158/0008-5472.CAN-10-4316. Epub 2011 Mar 28.

6.

Single round of antigen receptor signaling programs naive B cells to receive T cell help.

Damdinsuren B, Zhang Y, Khalil A, Wood WH 3rd, Becker KG, Shlomchik MJ, Sen R.

Immunity. 2010 Mar 26;32(3):355-66. doi: 10.1016/j.immuni.2010.02.013. Epub 2010 Mar 11.

7.

B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2.

Castro I, Wright JA, Damdinsuren B, Hoek KL, Carlesso G, Shinners NP, Gerstein RM, Woodland RT, Sen R, Khan WN.

J Immunol. 2009 Jun 15;182(12):7729-37. doi: 10.4049/jimmunol.0803281.

8.

Aberrant expression of connexin 26 is associated with lung metastasis of colorectal cancer.

Ezumi K, Yamamoto H, Murata K, Higashiyama M, Damdinsuren B, Nakamura Y, Kyo N, Okami J, Ngan CY, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Nojima H, Monden M.

Clin Cancer Res. 2008 Feb 1;14(3):677-84. doi: 10.1158/1078-0432.CCR-07-1184.

9.
10.

Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.

Wada H, Nagano H, Yamamoto H, Arai I, Ota H, Nakamura M, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Doki Y, Dono K, Nakamori S, Sakon M, Monden M.

Oncol Rep. 2007 Oct;18(4):801-9.

PMID:
17786339
11.

Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-alpha combination therapy following hepatic resection.

Wada H, Nagano H, Noda T, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Sakon M, Wakasa K, Monden M.

J Gastroenterol. 2007 Jun;42(6):501-6. Epub 2007 Jun 29.

PMID:
17671767
12.

Successful treatment of multiple hepatocellular carcinoma with tumor thrombi in the major portal branches by intraarterial 5-fluorouracil perfusion chemotherapy combined with subcutaneous interferon-alpha and hepatectomy.

Yamamoto T, Nagano H, Imai Y, Fukuda K, Matsumoto H, Kondo M, Ota H, Nakamura M, Wada H, Noda T, Damdinsuren B, Dono K, Umeshita K, Nakamori S, Sakon M, Wakasa K, Monden M.

Int J Clin Oncol. 2007 Apr;12(2):150-4. Epub 2007 Apr 27.

PMID:
17443284
13.

Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.

Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T, Ota H, Nakamura M, Wada H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshit K, Nakamori S, Monden M.

Hepatogastroenterology. 2007 Jan-Feb;54(73):172-9.

PMID:
17419255
14.

Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion.

Arai I, Nagano H, Kondo M, Yamamoto H, Hiraoka N, Sugita Y, Ota H, Yoshioka S, Nakamura M, Wada H, Damdinsuren B, Kato H, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshita K, Nakamori S, Wakasa K, Sakon M, Monden M.

Hepatogastroenterology. 2007 Jan-Feb;54(73):167-71.

PMID:
17419254
15.

Interferon alpha receptors are important for antiproliferative effect of interferon-alpha against human hepatocellular carcinoma cells.

Damdinsuren B, Nagano H, Wada H, Noda T, Natsag J, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Doki Y, Dono K, Monden M.

Hepatol Res. 2007 Jan;37(1):77-83.

PMID:
17300701
16.

Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection.

Yang Y, Nagano H, Ota H, Morimoto O, Nakamura M, Wada H, Noda T, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshita K, Nakamori S, Wakasa K, Sakon M, Monden M.

Surgery. 2007 Feb;141(2):196-202.

PMID:
17263976
17.

[Surgical treatment for peritoneal dissemination of hepatocellular carcinoma after percutaneous ethanol injection therapy--a case report].

Wada H, Nagano H, Noda T, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Wakasa K, Monden M.

Gan To Kagaku Ryoho. 2006 Nov;33(12):1935-7. Japanese.

PMID:
17212151
18.

[A successful case of hepatocellular carcinoma with portal venous tumor thrombus (Vp2) treated by transcatheter arterial chemoembolization].

Noda T, Nagano H, Miyamoto A, Wada H, Damdinsuren B, Marubashi S, Takeda Y, Umeshita K, Dono K, Ohsuga K, Kim T, Tomoda K, Nakamura H, Monden M.

Gan To Kagaku Ryoho. 2006 Nov;33(12):1931-4. Japanese.

PMID:
17212150
19.

[Intra arterial infusion chemotherapy combined with interferon-alpha following palliative hepatic resection against advanced hepatoma with portal venous tumor thrombus in the major trunk and multiple nodules--a preliminary study].

Nagano H, Miyamoto A, Wada H, Noda T, Nakamura M, Ota H, Damdinsuren B, Marubashi S, Takeda Y, Umeshita K, Dono K, Monden M.

Gan To Kagaku Ryoho. 2006 Nov;33(12):1848-51. Japanese.

PMID:
17212125
20.

A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chemotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-alpha.

Nakamura M, Nagano H, Wada H, Noda T, Ota H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Monden M.

J Gastroenterol. 2006 Nov;41(11):1120-5. Epub 2006 Dec 8.

PMID:
17160524
21.

Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.

Damdinsuren B, Nagano H, Wada H, Kondo M, Ota H, Nakamura M, Noda T, Natsag J, Yamamoto H, Doki Y, Umeshita K, Dono K, Nakamori S, Sakon M, Monden M.

Int J Oncol. 2007 Jan;30(1):201-8.

PMID:
17143530
22.

Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.

Nakamura M, Nagano H, Sakon M, Yamamoto T, Ota H, Wada H, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Nakamori S, Dono K, Monden M.

J Hepatol. 2007 Jan;46(1):77-88. Epub 2006 Sep 25.

PMID:
17045692
23.

Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology.

Takayama O, Yamamoto H, Damdinsuren B, Sugita Y, Ngan CY, Xu X, Tsujino T, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M.

Br J Cancer. 2006 Oct 9;95(7):889-95. Epub 2006 Sep 12.

24.

Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization.

Yasui M, Yamamoto H, Ngan CY, Damdinsuren B, Sugita Y, Fukunaga H, Gu J, Maeda M, Takemasa I, Ikeda M, Fujio Y, Sekimoto M, Matsuura N, Weinstein IB, Monden M.

Clin Cancer Res. 2006 Aug 1;12(15):4720-9.

25.

Expression of type I interferon receptor as a predictor of clinical response to interferon-alpha therapy of gastrointestinal cancers.

Ota H, Nagano H, Doki Y, Sekimoto M, Kondo M, Wada H, Nakamura M, Noda T, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshita K, Nakamori S, Wakasa K, Sakon M, Monden M.

Oncol Rep. 2006 Aug;16(2):249-55.

PMID:
16820899
26.

Vitamin K2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-alpha and fluorouracil in vitro.

Nakamura M, Nagano H, Noda T, Wada H, Ota H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Doki Y, Umeshita K, Dono K, Sakon M, Monden M.

Hepatol Res. 2006 Aug;35(4):289-95. Epub 2006 Jun 12.

PMID:
16769246
27.

Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.

Wada H, Nagano H, Yamamoto H, Yang Y, Kondo M, Ota H, Nakamura M, Yoshioka S, Kato H, Damdinsuren B, Tang D, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Nakamori S, Sakon M, Dono K, Wakasa K, Monden M.

Liver Int. 2006 May;26(4):414-23.

PMID:
16629644
28.

Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance.

Tang D, Nagano H, Yamamoto H, Wada H, Nakamura M, Kondo M, Ota H, Yoshioka S, Kato H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Wakasa K, Monden M.

Oncol Rep. 2006 Mar;15(3):525-32.

PMID:
16465407
29.

TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells.

Damdinsuren B, Nagano H, Kondo M, Natsag J, Hanada H, Nakamura M, Wada H, Kato H, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Monden M.

Oncol Rep. 2006 Feb;15(2):401-8.

PMID:
16391861
30.

Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.

Morimoto O, Nagano H, Miyamoto A, Fujiwara Y, Kondo M, Yamamoto T, Ota H, Nakamura M, Wada H, Damdinsuren B, Marubashi S, Dono K, Umeshita K, Nakamori S, Sakon M, Monden M.

Surg Today. 2005;35(12):1033-41.

PMID:
16341483
31.

[A successful surgical treatment for solitary pulmonary and adrenal metastases after hepatic resection to hepatocellular carcinoma--a case report].

Wada H, Nagano H, Nakamura M, Yoshioka S, Kato H, Noda T, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Monden M.

Gan To Kagaku Ryoho. 2005 Oct;32(11):1835-8. Japanese.

PMID:
16315956
32.

[A case of HCC with inferior caval vein tumor thrombus and multiple pulmonary metastases that remarkably responded to combination therapy of TS-1 and interferon-alpha].

Nakamura M, Nagano H, Sakon M, Yamamoto T, Ota H, Wada H, Yoshioka S, Kato H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Nakamori S, Dono K, Monden M.

Gan To Kagaku Ryoho. 2005 Oct;32(11):1824-8. Japanese.

PMID:
16315953
33.

Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells.

Hata T, Yamamoto H, Ngan CY, Koi M, Takagi A, Damdinsuren B, Yasui M, Fujie Y, Matsuzaki T, Hemmi H, Xu X, Kitani K, Seki Y, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M.

Mol Cancer Ther. 2005 Oct;4(10):1585-94.

34.

Pulmonary mucosa-associated lymphoid tissue type lymphoma with increased accumulation of fluorine 18-fluorodeoxyglucose on positron emission tomography.

Natsag J, Tomiyama N, Inoue A, Bryce TJ, Damdinsuren B, Honda O, Mihara N, Sumikawa H, Fujita S, Johkoh T, Hatazawa J, Nakamura H.

J Comput Assist Tomogr. 2005 Sep-Oct;29(5):640-3.

PMID:
16163034
35.

Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression.

Ota H, Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T, Nakamura M, Damdinsuren B, Wada H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Wakasa K, Monden M.

Br J Cancer. 2005 Sep 5;93(5):557-64.

36.

Effects of p21cip1/waf1 overexpression on growth, apoptosis and differentiation in human colon carcinoma cells.

Izawa H, Yamamoto H, Damdinsuren B, Ikeda K, Tsujie M, Suzuki R, Kitani K, Seki Y, Hayashi T, Takemasa I, Ikeda M, Ohue M, Sekimoto M, Monden T, Monden M.

Int J Oncol. 2005 Jul;27(1):69-76.

PMID:
15942645
37.

Methylation and expression of p16INK4 tumor suppressor gene in primary colorectal cancer tissues.

Kim BN, Yamamoto H, Ikeda K, Damdinsuren B, Sugita Y, Ngan CY, Fujie Y, Ogawa M, Hata T, Ikeda M, Ohue M, Sekimoto M, Monden T, Matsuura N, Monden M.

Int J Oncol. 2005 May;26(5):1217-26.

PMID:
15809712
38.

Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.

Kondo M, Nagano H, Wada H, Damdinsuren B, Yamamoto H, Hiraoka N, Eguchi H, Miyamoto A, Yamamoto T, Ota H, Nakamura M, Marubashi S, Dono K, Umeshita K, Nakamori S, Sakon M, Monden M.

Clin Cancer Res. 2005 Feb 1;11(3):1277-86.

39.

Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation.

Damdinsuren B, Nagano H, Kondo M, Yamamoto H, Hiraoka N, Yamamoto T, Marubashi S, Miyamoto A, Umeshita K, Dono K, Nakamori S, Wakasa K, Sakon M, Monden M.

Int J Oncol. 2005 Feb;26(2):319-27.

PMID:
15645115
40.

Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.

Yamamoto T, Nagano H, Sakon M, Wada H, Eguchi H, Kondo M, Damdinsuren B, Ota H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Yagita H, Monden M.

Clin Cancer Res. 2004 Dec 1;10(23):7884-95.

41.

[A case of long-term survivor with multiple pulmonary metastases of HCC after hepatic resection].

Nakamura M, Nagano H, Sakon M, Kondo M, Yamamoto T, Ota H, Wada H, Damdinsuren B, Yang Y, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Monden M.

Gan To Kagaku Ryoho. 2004 Oct;31(11):1939-42. Japanese.

PMID:
15553766
42.

[Successful treatment for advanced cholangiocellular carcinoma with intrahepatic metastasis and/or portal vein tumor thrombi by intraarterial chemotherapy combined with 5-fluorouracil, adriamycin and cisplatin (FAP)--two cases report].

Wada H, Nagano H, Dono K, Kondo M, Yamamoto T, Ota H, Nakamura M, Yoshioka S, Damdinsuren B, Yubo Y, Marubashi S, Miyamoto A, Umeshita K, Nakamori S, Sakon M, Monden M.

Gan To Kagaku Ryoho. 2004 Oct;31(11):1711-3. Japanese.

PMID:
15553691
43.

Hepatic expression of ANG2 RNA in metastatic colorectal cancer.

Ogawa M, Yamamoto H, Nagano H, Miyake Y, Sugita Y, Hata T, Kim BN, Ngan CY, Damdinsuren B, Ikenaga M, Ikeda M, Ohue M, Nakamori S, Sekimoto M, Sakon M, Matsuura N, Monden M.

Hepatology. 2004 Feb;39(2):528-39.

PMID:
14768007
44.

Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs.

Damdinsuren B, Nagano H, Sakon M, Kondo M, Yamamoto T, Umeshita K, Dono K, Nakamori S, Monden M.

Ann Surg Oncol. 2003 Dec;10(10):1184-90.

PMID:
14654475
45.

JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.

Yamamoto H, Kondo M, Nakamori S, Nagano H, Wakasa K, Sugita Y, Chang-De J, Kobayashi S, Damdinsuren B, Dono K, Umeshita K, Sekimoto M, Sakon M, Matsuura N, Monden M.

Gastroenterology. 2003 Aug;125(2):556-71.

PMID:
12891558
46.

Total synthesis of the antitumor acetogenin mosin B: desymmetrization approach to the stereodivergent synthesis of threo/trans/erythro-type acetogenins.

Maezaki N, Kojima N, Sakamoto A, Tominaga H, Iwata C, Tanaka T, Monden M, Damdinsuren B, Nakamori S.

Chemistry. 2003 Jan 20;9(2):389-99.

PMID:
12532287

Supplemental Content

Loading ...
Support Center